Does elevated urinary DHBMA indicate 1,3-butadiene exposure processing rather than glutathione depletion?

Urinary N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (DHBMA) is appropriately interpreted as a mercapturic-acid product of 1,3-butadiene metabolism, not as a direct assay of glutathione status.

Clinical and exposure interpretation

• DHBMA supports recent exposure-related metabolic processing of 1,3-butadiene when interpreted with collection timing and exposure context. Worker data suggest an approximately 10-hour urinary half-life with little accumulation over a workweek, favoring interpretation as a relatively recent rather than cumulative exposure marker.
• A raised result does not independently establish inhaled dose, source, or biologically effective DNA-reactive burden. Background DHBMA can occur without recognized occupational exposure, and associations with smoking have been inconsistent.
• Interpretation is strengthened by urine-dilution adjustment, smoking and occupational/environmental history, timing of collection, and—where useful—complementary biomarkers such as MHBMA. Population reference distributions are not clinical toxicity thresholds.

Mechanistic basis

• The supported pathway begins with cytochrome P450 oxidation of 1,3-butadiene to 3,4-epoxy-1-butene, followed by epoxide-hydrolase conversion to butenediol and further metabolism.
• Glutathione conjugation contributes to formation of the downstream N-acetylcysteine mercapturate excreted as DHBMA. The precise immediate conjugation substrate is less certain, variably described as butenediol or the downstream oxidation product hydroxymethylvinyl ketone.
• This differs from direct conjugation of the initial epoxide, which is associated with the distinct mercapturate MHBMA.

Glutathione implications

• Bottom line: An elevated DHBMA indicates that glutathione-linked detoxification/mercapturate processing has occurred, but it is not direct proof of glutathione depletion in blood or tissues. Establishing depletion would require independent measurement of glutathione status rather than inference from urinary DHBMA alone.